SCHEMBL3706372

SCHEMBL3706372

O=C(O)c1sccc1NO

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 1/20 0.63
PTPN1 P18031 1/20 0.63
ABCC1 P33527 1/20 0.54
KMT2A Q03164 6/20 0.53
MEN1 O00255 5/20 0.53
NPC1 O15118 5/20 0.53
RAB9A P51151 4/20 0.53
ACLY P53396 1/20 0.49
AXL P30530 1/20 0.43
LMNA P02545 1/20 0.43
NPSR1 Q6W5P4 2/20 0.42
PRNP P04156 1/20 0.42
PPARG P37231 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
NCOR2 Q9Y618 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23931980 0.81 PTPN2 (0.72) PTPN2PTPN1ABCC1KMT2AMEN1
SCHEMBL3580345 0.81 PTPN2 (0.61) PTPN2PTPN1ABCC1KMT2AMEN1
SCHEMBL27730366 0.79 PTPN2 (0.59) PTPN2PTPN1ABCC1KMT2AMEN1
SCHEMBL3247888 0.78 PTPN2 (0.68) PTPN2PTPN1ABCC1KMT2AMEN1
SCHEMBL28312814 0.78 PTPN2 (0.58) PTPN2PTPN1ABCC1KMT2AMEN1
SCHEMBL16413175 0.78 PTPN2 (0.58) PTPN2PTPN1ABCC1KMT2AMEN1
SCHEMBL5838354 0.78 PTPN1 (1.00) PTPN2PTPN1ABCC1KMT2AMEN1
SCHEMBL15846889 0.78 NPC1 (0.65) KMT2AMEN1NPC1LMNANPSR1
SCHEMBL1704250 0.78 PTPN2 (0.68) PTPN2PTPN1ABCC1KMT2AMEN1
SCHEMBL11350331 0.76 PTPN2 (0.56) PTPN2PTPN1ABCC1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2195029-A2 TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES Oryzon Genomics SA (ES) 2010-06-16 EP disclosed
WO-2009027349-A2 TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES ORYZON GENOMICS SA (ES) 2009-03-05 WO disclosed